The genetics of venous thromboembolism: a systematic review of thrombophilia families
- PMID: 32623564
- DOI: 10.1007/s11239-020-02203-7
The genetics of venous thromboembolism: a systematic review of thrombophilia families
Abstract
Genetic risk factors are important for the occurrence and prognosis of venous thromboembolism (VTE). The studies of thrombophilia families are important for dissecting the genetic background of the thrombotic disease. We conducted the systematic review of all published family-based studies on VTE genetics across all racial groups through PubMed and Embase prior to 13th April 2020. This systematic review of 287 families (including 225 Caucasian families, 52 East Asian families, and families of other ethnicities) revealed a total of 21 different genes; the five most reported mutated genes were F5 (88/287, 30.7%), SERPINC1 (67/287, 23.3%), PROC (65/287, 22.6%), F2 (40/287, 13.9%) and PROS1 (48/287, 16.7%). For Caucasian families, F5 mutations were most frequently reported at 37.8% (85/225), while PROS1 mutations were most frequently reported, at 40.4% (21/52), for East Asian families (Chinese, Japanese and Korean). Factor V Leiden was reported more frequently in Caucasians than in East Asians. Missense mutations were reported frequently in the SERPINC1, PROC and PROS1 genes. In conclusion, our study found the most likely mutated genes associated with VTE among different ethnic groups and provided indications for VTE genetic testing and research in the future.
Keywords: Family study; Genes; Systematic review; Venous thromboembolism.
References
-
- Shahi A, Chen AF, Tan TL, Maltenfort MG, Kucukdurmaz F, Parvizi J (2017) The incidence and economic burden of in-hospital venous thromboembolism in the United States. J Arthroplast 32(4):1063–1066. https://doi.org/10.1016/j.arth.2016.10.020 - DOI
-
- Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, Hylek EM, Kakkar A, Konstantinides SV, McCumber M, Ozaki Y, Wendelboe A, Weitz JI, Day ISCfWT (2014) Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 34(11):2363–2371. https://doi.org/10.1161/ATVBAHA.114.304488 - DOI - PubMed
-
- Zhang Z, Lei J, Shao X, Dong F, Wang J, Wang D, Wu S, Xie W, Wan J, Chen H, Ji Y, Yi Q, Xu X, Yang Y, Zhai Z, Wang C, China Venous Thromboembolism Study G (2019) Trends in hospitalization and in-hospital mortality from VTE, 2007 to 2016, in China. Chest 155(2):342–353. https://doi.org/10.1016/j.chest.2018.10.040 - DOI - PubMed
-
- Morange PE, Suchon P, Tregouet DA (2015) Genetics of venous thrombosis: update in 2015. Thromb Haemost 114(5):910–919. https://doi.org/10.1160/TH15-05-0410 - DOI - PubMed
-
- Tregouet DA, Morange PE (2018) What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies. Br J Haematol 180(3):335–345. https://doi.org/10.1111/bjh.15004 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
